Skip to main content

Animations

MJFF Publications

2371 - 2380 of 9134 Results
Title
Year
  • Year
  • 2021
  • 2023
  • 2024
  • 2024
  • 2022
  • 2016
  • 2013
  • 2023
  • 2016
  • 2021
  • Summary Details
    OPEN
    Title: Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28886
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in Isolated Rapid Eye Movement Sleep Behavior Disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29306
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mdc3.14043
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/psp4.13112
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®
    Journal Name: European Radiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00330-021-08385-9
    Citation Count: 19
  • Summary Details
    OPEN
    Title: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2
    Citation Count: 224
  • Summary Details
    OPEN
    Title: CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-013-1148-z
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-239901
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson’s Disease
    Journal Name: Cell Stem Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.stem.2016.08.002
    Citation Count: 471
  • Summary Details
    OPEN
    Title: The commercial genetic testing landscape for Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.